TEST. SELECT. TREAT
25% of people suffer from obstructive sleep apnea (OSA) – let’s give them a treatment option they will actually use.
Zephyr’s scientifically-validated medical devices and technologies are revolutionizing how OSA is being diagnosed and treated.
Used world-wide by sleep labs, physicians, dentists and leading-edge sleep researchers, our products are evolving the landscape of the sleep industry.
Powered by continuous innovation, our proprietary technologies are setting the stage to help the millions of OSA patients get the treatment they need.
Our MATRx Technology – Predicting Success with Oral Appliance Therapy
WHAT WE KNOW
Oral appliances work, but they don’t work for everyone!
We need methods to SELECT OSA patients who will be effectively treated with an oral appliance.
A MATRx test
MATRx simplifies patient selection for oral appliance therapy.
How? By identifying responders and an effective protrusive position in advance of appliance fitting.
- Knowing who to treat gives your patients confidence in therapy
- Accurate prediction of target protrusion eliminates guesswork, the risk of needless over-protrusion, and saves chair time.
The Clinical Practice Guideline for the treatment of obstructive sleep apnea (OSA) and snoring with oral appliance therapy was updated in June 2015 and published in the Journal of Clinical Sleep Medicine. The guideline expand the role of oral appliances in OSA treatment.
MATRx plus | At-home Sleep Theragnostic
MATRx plus is the first at-home auto-titration device that performs both a sleep study and a sleep theragnostic test.
MATRx | In-lab Polysomnographic Study
MATRx integrates with the polysomnogram (PSG) to allow monitoring of the patient during a single night, remote-controlled titration study.